Clinical Trials List
Protocol NumberAK-US-001-0107
2024-01-12 - 2026-09-11
Phase III
Recruiting1
ICD-10K74.4
Secondary biliary cirrhosis
ICD-10K75.81
Nonalcoholic steatohepatitis (NASH)
ICD-10K76.0
Fatty (change of) liver, not elsewhere classified
ICD-10K76.89
Other specified diseases of liver
ICD-10R16.2
Hepatomegaly with splenomegaly, not elsewhere classified
ICD-9571.8
Other chronic nonalcoholic liver disease
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2024/02/21
Investigators and Locations
Co-Principal Investigator
- Shih-Jer Hsu 無
- Chen-Hua Liu 無
- 洪俊銘 無
- Chun-Jen Liu 無
- Tiffany Ting-Fang Shih 無
- 楊宏志 無
- 吳志宏 無
- 曾岱宗 無
- 蘇東弘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
580 participants
